According to an industry report, pharmaceutical organizations see a 40% decline in adherence rate within a year of trial commencement. How can they tackle it? How has the COVID-19 pandemic impacted the already complex medication flows? What constitutes the next-generation medication management, and how can organizations enable it?
Our article focuses on next-generation medication management with insights on smart technologies and synergistic partnerships, backed by real-life implementation use cases. Emphasizing on personalized patient support, integrated medication ecosystem, and flexible medication processes, the article envisions the next-generation of medication management that will be fuelled by innovative technologies and symbiotic partnerships, and help us realize preventive, augmented, and embedded smart medication management.